KemPharm (KMPH) Files Amendment to Apadaz NDA; Focuses on Providing Additional Info Amid Review
Tweet Send to a Friend
KemPharm, Inc. (Nasdaq: KMPH) announced that it has filed with the U.S. Food and Drug Administration (FDA) an amendment request ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
